Ryan H. Siurek
Known title: Chief Financial OfficerCIK: 0001476512
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
Biodesix Expands MRD Monitoring Through New Partnerships. Biodesix announced progress in two collaborative programs aimed at tumor‑informed and tumor‑naïve molecular residual disease (MRD) solutions. The company also advanced its MRD monitoring programs by partnering with Bio‑Rad and Thermo Fisher. These developments broaden Biodesix’s portfolio of diagnostic tools for cancer patients.
Transaction History
| EVCM | ▼ Sell | Tax Withholding | 2,606 | $21K | 9/5/2026 | View on chart |
| EVCM | ▼ Sell | Tax Withholding | 2,800 | $22K | 9/5/2026 | View on chart |
| EVCM | ▼ Sell | Tax Withholding | 1,396 | $13K | 8/22/2026 | View on chart |
| EVCM | ▼ Sell | Tax Withholding | 606 | $6K | 8/20/2026 | View on chart |
| EVCM | ▼ Sell | Open Market | 3,188 | $32K | 8/19/2026 | View on chart |
| EVCM | ▼ Sell | Open Market | 16,812 | $172K | 8/17/2026 | View on chart |
| EVCM | ▼ Sell | Tax Withholding | 1,067 | $11K | 8/14/2026 | View on chart |
| EVCM | ▼ Sell | Tax Withholding | 3,956 | $36K | 6/5/2026 | View on chart |
| EVCM | ▼ Sell | Tax Withholding | 4,248 | $39K | 6/5/2026 | View on chart |
| EVCM | ▼ Sell | Tax Withholding | 1,397 | $15K | 5/22/2026 | View on chart |
| EVCM | ▼ Sell | Tax Withholding | 399 | $4K | 5/20/2026 | View on chart |
| EVCM | ▼ Sell | Tax Withholding | 703 | $7K | 5/14/2026 | View on chart |
| EVCM | ▲ Buy | Grant | 154,537 | $0 | 3/5/2026 | View on chart |
| EVCM | ▼ Sell | Tax Withholding | 2,727 | $33K | 3/5/2026 | View on chart |
| EVCM | ▼ Sell | Tax Withholding | 1,652 | $17K | 2/23/2026 | View on chart |
| EVCM | ▼ Sell | Tax Withholding | 472 | $5K | 2/20/2026 | View on chart |
| EVCM | ▼ Sell | Open Market | 832 | $9K | 2/14/2026 | View on chart |
| EVCM | ▼ Sell | Open Market | 8,300 | $102K | 12/15/2025 | View on chart |
| EVCM | ▼ Sell | Tax Withholding | 2,607 | $26K | 12/5/2025 | View on chart |
| EVCM | ▼ Sell | Tax Withholding | 1,396 | $12K | 11/22/2025 | View on chart |
| EVCM | ▼ Sell | Tax Withholding | 399 | $3K | 11/20/2025 | View on chart |
| EVCM | ▼ Sell | Tax Withholding | 704 | $6K | 11/17/2025 | View on chart |
| EVCM | ▼ Sell | Tax Withholding | 2,607 | $30K | 9/5/2025 | View on chart |
| EVCM | ▼ Sell | Tax Withholding | 1,397 | $16K | 8/22/2025 | View on chart |
| EVCM | ▼ Sell | Tax Withholding | 399 | $4K | 8/20/2025 | View on chart |
| EVCM | ▼ Sell | Open Market | 10,000 | $106K | 8/14/2025 | View on chart |
| EVCM | ▼ Sell | Tax Withholding | 703 | $7K | 8/14/2025 | View on chart |
| EVCM | ▼ Sell | Tax Withholding | 2,606 | $27K | 6/5/2025 | View on chart |
| EVCM | ▼ Sell | Tax Withholding | 1,396 | $14K | 5/22/2025 | View on chart |
| EVCM | ▼ Sell | Tax Withholding | 399 | $4K | 5/20/2025 | View on chart |
| EVCM | ▼ Sell | Tax Withholding | 704 | $8K | 5/14/2025 | View on chart |
| EVCM | ▼ Sell | Other | 10,000 | $113K | 5/13/2025 | View on chart |
| EVCM | ▲ Buy | Grant | 143,885 | $0 | 3/5/2025 | View on chart |
| EVCM | ▼ Sell | Tax Withholding | 1,652 | $17K | 2/22/2025 | View on chart |
| EVCM | ▼ Sell | Tax Withholding | 472 | $5K | 2/20/2025 | View on chart |
| EVCM | ▼ Sell | Tax Withholding | 832 | $9K | 2/14/2025 | View on chart |
| EVCM | ▼ Sell | Tax Withholding | 1,396 | $17K | 11/22/2024 | View on chart |
| EVCM | ▼ Sell | Tax Withholding | 399 | $4K | 11/20/2024 | View on chart |
| EVCM | ▼ Sell | Tax Withholding | 703 | $8K | 11/14/2024 | View on chart |
| EVCM | ▼ Sell | Tax Withholding | 1,397 | $14K | 8/22/2024 | View on chart |
| EVCM | ▲ Buy | Grant | 22,016 | $0 | 8/20/2024 | View on chart |
| EVCM | ▼ Sell | Tax Withholding | 2,812 | $27K | 8/14/2024 | View on chart |
| EVCM | ▼ Sell | Open Market | 1,471 | $15K | 5/28/2024 | View on chart |
| EVCM | ▲ Buy | Grant | 77,081 | $0 | 2/22/2024 | View on chart |
| EVCM | ▲ Buy | Grant | 38,806 | $0 | 8/14/2023 | View on chart |
| BDSX | ▼ Sell | Open Market | 564 | $889 | 5/10/2023 | View on chart |
| BDSX | ▼ Sell | Open Market | 1,456 | $2K | 5/9/2023 | View on chart |
| BDSX | ▲ Buy | Option Exercise | 5,484 | — | 5/8/2023 | View on chart |
| BDSX | ▼ Sell | Open Market | 2,016 | $4K | 2/9/2023 | View on chart |
| BDSX | ▲ Buy | Option Exercise | 5,483 | — | 2/8/2023 | View on chart |
| BDSX | ▲ Buy | Grant | 8,695 | $10K | 11/21/2022 | View on chart |
| BDSX | ▼ Sell | Open Market | 762 | $775 | 11/10/2022 | View on chart |
| BDSX | ▼ Sell | Open Market | 963 | $1K | 11/9/2022 | View on chart |
| BDSX | ▲ Buy | Option Exercise | 5,482 | — | 11/8/2022 | View on chart |
| BDSX | ▼ Sell | Open Market | 1,645 | $4K | 8/9/2022 | View on chart |
| BDSX | ▲ Buy | Option Exercise | 5,484 | — | 8/8/2022 | View on chart |
| BDSX | ▼ Sell | Open Market | 1,947 | $4K | 5/10/2022 | View on chart |
| BDSX | ▲ Buy | Option Exercise | 5,484 | — | 5/9/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
EverCommerce Leadership Changes Prompt Strategy Questions
EverCommerce is facing questions about whether its recent leadership changes represent a strategic shift or just an organizational update. The company is also mentioned in a broader context of healthcare automation efforts aimed at reducing administrative costs. These developments occur while the stock trades near its support level, with analysts maintaining a mixed outlook on its valuation.
EverCommerce Leadership Changes Prompt Strategy Questions. EverCommerce is facing questions about whether its recent leadership changes represent a strategic shift or just an organizational update. The company is also mentioned in a broader context of healthcare automation efforts aimed at reducing administrative costs. These developments occur while the stock trades near its support level, with analysts maintaining a mixed outlook on its valuation.